379 related articles for article (PubMed ID: 28386699)
1. Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.
Kraehenmann R; Pokorny D; Vollenweider L; Preller KH; Pokorny T; Seifritz E; Vollenweider FX
Psychopharmacology (Berl); 2017 Jul; 234(13):2031-2046. PubMed ID: 28386699
[TBL] [Abstract][Full Text] [Related]
2. LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.
Kraehenmann R; Pokorny D; Aicher H; Preller KH; Pokorny T; Bosch OG; Seifritz E; Vollenweider FX
Front Pharmacol; 2017; 8():814. PubMed ID: 29167644
[No Abstract] [Full Text] [Related]
3. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
Elife; 2018 Oct; 7():. PubMed ID: 30355445
[TBL] [Abstract][Full Text] [Related]
4. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
[TBL] [Abstract][Full Text] [Related]
7. The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation.
Preller KH; Herdener M; Pokorny T; Planzer A; Kraehenmann R; Stämpfli P; Liechti ME; Seifritz E; Vollenweider FX
Curr Biol; 2017 Feb; 27(3):451-457. PubMed ID: 28132813
[TBL] [Abstract][Full Text] [Related]
8. LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making.
Pokorny T; Duerler P; Seifritz E; Vollenweider FX; Preller KH
Psychol Med; 2020 Oct; 50(13):2255-2264. PubMed ID: 31500679
[TBL] [Abstract][Full Text] [Related]
9. Role of the 5-HT
Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
[TBL] [Abstract][Full Text] [Related]
10. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
[TBL] [Abstract][Full Text] [Related]
11. LSD-induced increases in social adaptation to opinions similar to one's own are associated with stimulation of serotonin receptors.
Duerler P; Schilbach L; Stämpfli P; Vollenweider FX; Preller KH
Sci Rep; 2020 Jul; 10(1):12181. PubMed ID: 32699231
[TBL] [Abstract][Full Text] [Related]
12. Acute LSD effects on response inhibition neural networks.
Schmidt A; Müller F; Lenz C; Dolder PC; Schmid Y; Zanchi D; Lang UE; Liechti ME; Borgwardt S
Psychol Med; 2018 Jul; 48(9):1464-1473. PubMed ID: 28967351
[TBL] [Abstract][Full Text] [Related]
13. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
Holze F; Vizeli P; Ley L; Müller F; Dolder P; Stocker M; Duthaler U; Varghese N; Eckert A; Borgwardt S; Liechti ME
Neuropsychopharmacology; 2021 Feb; 46(3):537-544. PubMed ID: 33059356
[TBL] [Abstract][Full Text] [Related]
14. Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.
Becker AM; Klaiber A; Holze F; Istampoulouoglou I; Duthaler U; Varghese N; Eckert A; Liechti ME
Int J Neuropsychopharmacol; 2023 Feb; 26(2):97-106. PubMed ID: 36342343
[TBL] [Abstract][Full Text] [Related]
15. Effective connectivity changes in LSD-induced altered states of consciousness in humans.
Preller KH; Razi A; Zeidman P; Stämpfli P; Friston KJ; Vollenweider FX
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2743-2748. PubMed ID: 30692255
[TBL] [Abstract][Full Text] [Related]
16. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
Jalal B
Psychopharmacology (Berl); 2018 Nov; 235(11):3083-3091. PubMed ID: 30288594
[TBL] [Abstract][Full Text] [Related]
17. Role of the serotonin 5-HT(2A) receptor in learning.
Harvey JA
Learn Mem; 2003; 10(5):355-62. PubMed ID: 14557608
[TBL] [Abstract][Full Text] [Related]
18. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
Gresch PJ; Strickland LV; Sanders-Bush E
Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
[TBL] [Abstract][Full Text] [Related]
20. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
Burris KD; Sanders-Bush E
Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
